Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Amgen
Company Monitoring Page for Amgen
job ratings (see below graph) for Amgen
latest headlines for company on cafepharma
Are Celgene and Amgen Undervalued By the Market?
Motley Fool
Sat, 04/12/14 - 10:11 am
Tags:
Amgen
,
Celgene
Amgen Spiking Lower 1.5%, Says Primary Endpoint of Durable Response Rate Met in Phase 3 Study of Talimogene, Secondary Endpoint Not Met
Yahoo/Benzinga
Fri, 04/4/14 - 09:14 am
Tags:
Amgen
,
Talimogene Laherparepvec
,
melanoma
Amgen ends marketing agreement with GSK for osteoporosis drug
Yahoo/Reuters
Thu, 04/3/14 - 05:48 pm
Tags:
Amgen
,
GSK
,
osteoporosis
,
Prolia
Xencor Inc.: Current Biotech Uncertainty Is An Opportunity
Seeking Alpha
Thu, 04/3/14 - 09:36 am
Tags:
Xencor
,
Amgen
,
Roche
,
antibodies
,
Biogen Idec
Study: New Cholesterol Drugs Effectively Lower LDL Levels
Wall St Cheat Sheet
Tue, 04/1/14 - 08:16 am
Tags:
cholesterol
,
Amgen
,
Sanofi
,
Regeneron
,
PCSK9 inhibitors
Amgen Drug Cuts Cholesterol Levels In Pivotal Studies
TheStreet.com
Mon, 03/31/14 - 10:18 am
Tags:
Amgen
,
cholesterol
,
evolocumab
Amgen Drug Slashes Bad Cholesterol Within Weeks of Treatment
Bloomberg
Sun, 03/30/14 - 10:35 am
Tags:
Amgen
,
cholesterol
,
evolocumab
New Cholesterol Fighters To Take Center Stage At ACC
Investors.com
Fri, 03/28/14 - 10:22 am
Tags:
cholesterol
,
Pfizer
,
Amgen
,
Regeneron
,
Sanofi
,
PCSK9 inhibitors
,
American Cardiology Conference
,
alirocumab
Amgen - On Course To Change The Future
Seeking Alpha
Thu, 03/27/14 - 11:00 am
Tags:
Amgen
Large Cap Biopharmaceuticals Are Core Holdings After Sell-Off: AbbVie, Amgen, Gilead
Seeking Alpha
Wed, 03/26/14 - 08:30 am
Tags:
AbbVie
,
Amgen
,
Gilead Sciences
,
Achillion
,
Alexion
,
Ariad Pharmaceuticals
,
Pharmacyclics
,
Seattle Genetics
JPMorgan Sees No Bubble, Hears No Bubble as Biotech Falls Again
Barron's
Mon, 03/24/14 - 11:29 am
Tags:
biotech
,
Biogen Idec
,
Amgen
,
Celgene
,
Gilead Sciences
,
Regeneron
Amgen drug meets goal for those with high genetic cholesterol
Yahoo/Reuters
Mon, 03/17/14 - 10:25 am
Tags:
Amgen
,
cholesterol
,
evolocumab
Amgen's talimogene laherparepvec reduced size of tumors in Phase 3 study
Yahoo/The Fly on the Wall
Sat, 03/15/14 - 10:03 am
Tags:
Amgen
,
Talimogene Laherparepvec
,
melanoma
With FDA Concerns Public, What's Next for These Cholesterol Drugs?
Motley Fool
Thu, 03/13/14 - 05:55 pm
Tags:
FDA
,
Regeneron
,
Pfizer
,
Amgen
,
PCSK9 inhibitors
Better Buy: Biogen Or Amgen?
Motley Fool
Sat, 03/8/14 - 10:39 am
Tags:
Amgen
,
Biogen
3 Stocks Boosting The Drugs Industry Higher
TheStreet.com
Thu, 02/27/14 - 05:00 pm
Tags:
Intercept Pharma
,
Amgen
,
Pfizer
Pharma shelled out $3.75B in fraud penalties in record-setting year, feds say
Fierce Pharma
Wed, 02/26/14 - 11:12 am
Tags:
fraud
,
Abbott Labs
,
Amgen
,
Ranbaxy
,
Wyeth
,
Pfizer
,
Sanofi
AbbVie, Amgen and Roche most vulnerable to biosim rivals, Moody's says
Fierce Pharma
Tue, 02/25/14 - 03:58 pm
Tags:
AbbVie
,
Amgen
,
Roche
,
biosimilars
Biotech: Too Big for Its Britches?
Barron's
Mon, 02/24/14 - 05:05 pm
Tags:
biotech
,
Celgene
,
Gilead Sciences
,
Biogen Idec
,
Amgen
,
Regeneron
Amgen Inc's Deep Pipeline Offsets Some of the Price Risk
Motley Fool
Wed, 02/12/14 - 10:07 am
Tags:
Amgen
,
earnings
,
evolocumab
Pages
« first
‹ previous
…
63
64
65
66
67
68
69
70
71
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.